Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Mar 2019 Transparency Market Research Healthcare190 Pages Price :
$ 5795

Global Cardiac Biomarker Diagnostic Kits Market: Overview

This report on the global cardiac biomarker diagnostic kits market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on disease indication, product, testing, and end-user. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises a competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global cardiac biomarker diagnostic kits market. 

Global Cardiac Biomarker Diagnostic Kits Market: Key Segments

Based on disease indication, the global cardiac biomarker diagnostic kits market has been segmented into angina pectoris, myocardial infraction, cardiac heart failure, and others. In terms of testing, the market has been classified into laboratory testing and point of care testing. In terms of product, the market has been classified into troponin test kits, CK-MB test kits, myoglobin test kits, BNP Test Kit, C-reactive Protein (hsCRP), and other biomarkers. Based on end-user, the market has been categorized into hospitals, clinics, diagnostics centers, and others. The global cardiac biomarker diagnostic kits market has been analyzed based on increasing regulatory scrutiny, technology trends, expenditure on emerging technologies and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. 

Global Cardiac Biomarker Diagnostic Kits Market: Regional Outlook

In terms of region, the global cardiac biomarker diagnostic kits market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period 2018-2026, considering 2017 as the base year. 

Companies Mentioned in the Report

The report profiles major players operating in the global Cardiac Biomarker Diagnostic Kits market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Abbott Laboratories, Hoffmann-La Roche AG, Bio-Rad Laboratories, Danaher Corporation, Seimens Healthineers, Thermofisher Scientific, bioMérieux, Randox Laboratories Ltd., and Ortho Clinical Diagnostics. 

The global cardiac biomarker diagnostic kits market has been segmented as follows:

Global Cardiac Biomarker Diagnostic Kits Market, by Disease Indication

  • Angina pectoris
  • Myocardial Infraction (MI)
  • Cardiac Heart Failure
  • Others

Global Cardiac Biomarker Diagnostic Kits Market, by Product

  • Troponin Test Kits
  • CK-MB Test Kits
  • Myoglobin Test Kits
  • BNP Test Kit
  • C-reactive Protein (hsCRP)
  • Other Biomarkers (galectin-3, H-FABP, myeloperoxidase, ischemia-modified albumin, and homocysteine)

Global Cardiac Biomarker Diagnostic Kits Market, Testing

  • Laboratory Testing
  • Pont-of-care Testing

Global Cardiac Biomarker Diagnostic Kits Market, by End-user

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Global Cardiac Biomarker Diagnostic Kits Market, by Region

  • North America
  • U.S
  • Canada
  • Europe
  • Germany
  • U.K
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Australia & New Zealand
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market

4. Market Overview
4.1. Introduction
4.1.1. Products Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Mergers & Acquisitions
5.3. Reimbursement Scenario 
5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries
5.5. Top 3 players operating in the market space

6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Product 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
6.3.1. Troponin Test Kits 
6.3.2. CK-MB Test Kits
6.3.3. Myoglobin Test Kits
6.3.4. BNP Test Kit
6.3.5. C-reactive Protein (hsCRP)
6.3.6. Others
6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product 

7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
7.3.1. Laboratory Testing
7.3.2. Pont-of-care Testing
7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing 

8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Disease Indication 
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
8.3.1. AngiStent Type Pectoris
8.3.2. Myocardial Infraction
8.3.3. Cardiac Heart Failure
8.3.4. Other
8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication 

9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user 
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Diagnostic Laboratory
9.3.4. Others
9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user 

10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region
10.2.1. North America 
10.2.2. Europe 
10.2.3. Asia Pacific 
10.2.4. Latin America 
10.2.5. Middle East & Africa 
10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region

11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
11.2.1. Troponin Test Kits 
11.2.2. CK-MB Test Kits
11.2.3. Myoglobin Test Kits
11.2.4. BNP Test Kit
11.2.5. C-reactive Protein (hsCRP)
11.2.6. Others
11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
11.3.1. Laboratory Testing
11.3.2. Pont-of-care Testing
11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
11.4.1. AngiStent Type Pectoris
11.4.2. Myocardial Infraction
11.4.3. Cardiac Heart Failure
11.4.4. Other
11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Diagnostic Laboratory
11.5.4. Others
11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2016–2026
11.6.1. U.S.
11.6.2. Canada
11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
11.7.1. By Product 
11.7.2. By Testing 
11.7.3. By Disease Indication 
11.7.4. By End-user 
11.7.5. By Country

12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
12.2.1. Troponin Test Kits 
12.2.2. CK-MB Test Kits
12.2.3. Myoglobin Test Kits
12.2.4. BNP Test Kit
12.2.5. C-reactive Protein (hsCRP)
12.2.6. Others
12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
12.3.1. Laboratory Testing
12.3.2. Pont-of-care Testing
12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
12.4.1. AngiStent Type Pectoris
12.4.2. Myocardial Infraction
12.4.3. Cardiac Heart Failure
12.4.4. Other
12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic Laboratory
12.5.4. Others
12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
12.7.1. By Product 
12.7.2. By Testing 
12.7.3. by Disease Indication 
12.7.4. by End-user 
12.7.5. by Country/Sub-region

13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
13.2.1. Troponin Test Kits 
13.2.2. CK-MB Test Kits
13.2.3. Myoglobin Test Kits
13.2.4. BNP Test Kit
13.2.5. C-reactive Protein (hsCRP)
13.2.6. Others
13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
13.3.1. Laboratory Testing
13.3.2. Pont-of-care Testing
13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
13.4.1. AngiStent Type Pectoris
13.4.2. Myocardial Infraction
13.4.3. Cardiac Heart Failure
13.4.4. Other
13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic Laboratory
13.5.4. Others
13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
13.7.1. By Product 
13.7.2. By Testing 
13.7.3. By Disease Indication 
13.7.4. By End-user 
13.7.5. By Country/Sub-region

14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
14.2.1. Troponin Test Kits 
14.2.2. CK-MB Test Kits
14.2.3. Myoglobin Test Kits
14.2.4. BNP Test Kit
14.2.5. C-reactive Protein (hsCRP)
14.2.6. Others
14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
14.3.1. Laboratory Testing
14.3.2. Pont-of-care Testing
14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
14.4.1. AngiStent Type Pectoris
14.4.2. Myocardial Infraction
14.4.3. Cardiac Heart Failure
14.4.4. Other
14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic Laboratory
14.5.4. Others
14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
14.7.1. By Product 
14.7.2. By Testing 
14.7.3. By Disease Indication 
14.7.4. By End-user 
14.7.5. By Country/Sub-region

15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
15.2.1. Troponin Test Kits 
15.2.2. CK-MB Test Kits
15.2.3. Myoglobin Test Kits
15.2.4. BNP Test Kit
15.2.5. C-reactive Protein (hsCRP)
15.2.6. Others
15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
15.3.1. Laboratory Testing
15.3.2. Pont-of-care Testing
15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
15.4.1. AngiStent Type Pectoris
15.4.2. Myocardial Infraction
15.4.3. Cardiac Heart Failure
15.4.4. Other
15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Diagnostic Laboratory
15.5.4. Others
15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
15.7.1. By Product 
15.7.2. By Testing 
15.7.3. By Disease Indication 
15.7.4. By End-user 
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis by Company (2017)
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1. Abbott Laboratories Ltd.
16.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.1.2. Business Overview
16.4.1.3. Product Portfolio 
16.4.1.4. Financial Overview 
16.4.1.5. SWOT Analysis 
16.4.2. Hoffmann-La Roche AG
16.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.2.2. Business Overview
16.4.2.3. Product Portfolio 
16.4.2.4. Financial Overview 
16.4.2.5. SWOT Analysis 
16.4.3. Bio-Rad Laboratories
16.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.3.2. Business Overview
16.4.3.3. Product Portfolio 
16.4.3.4. Financial Overview 
16.4.3.5. SWOT Analysis 
16.4.4. Danaher Corporation
16.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.4.2. Business Overview
16.4.4.3. Product Portfolio 
16.4.4.4. Financial Overview 
16.4.4.5. SWOT Analysis 
16.4.5. Seimens Healthineers
16.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.5.2. Business Overview
16.4.5.3. Product Portfolio 
16.4.5.4. Financial Overview 
16.4.5.5. SWOT Analysis 
16.4.6. Thermofisher Scientific
16.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.6.2. Business Overview
16.4.6.3. Product Portfolio 
16.4.6.4. Financial Overview 
16.4.6.5. SWOT Analysis 
16.4.7. bioMérieux
16.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.7.2. Business Overview
16.4.7.3. Product Portfolio 
16.4.7.4. Financial Overview 
16.4.7.5. SWOT Analysis 
16.4.8. Ortho Clinical Diagnostics 
16.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.8.2. Business Overview
16.4.8.3. Product Portfolio 
16.4.8.4. Financial Overview 
16.4.8.5. SWOT Analysis 

List of Table

List of Tables

Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

List of Chart

List of Figures

Figure 01: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 02: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Troponin Test Kits, 2016–2026
Figure 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by CK-MB Test Kits, 2016–2026
Figure 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myoglobin Test Kits, 2016–2026
Figure 06: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by BNP Test Kit, 2016–2026
Figure 07: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (hsCRP), 2016–2026
Figure 08: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Other Biomarkers, 2016–2026
Figure 09: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 10: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 11: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Angina Pectoris, 2016–2026
Figure 12: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myocardial Infraction (MI), 2016–2026
Figure 13: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Cardiac Heart Failure, 2016–2026
Figure 14: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 15: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 16: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Laboratory Testing, 2016–2026
Figure 17: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Pont-of-care testing, 2016–2026
Figure 18: Global Cardiac Biomarker Diagnostic Kits  Market Attractiveness Analysis, by Testing, 2018–2026
Figure 19: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 20: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
Figure 21: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016–2026
Figure 22: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratory, 2016–2026
Figure 23: Global Cardiac Biomarker Diagnostic Kits  Market Attractiveness Analysis, by End-user, 2018–2026
Figure 24: Cardiac Biomarker Diagnostic Kits  Market Value Share Analysis, by Region, 2017 and 2026
Figure 25: Global Cardiac Biomarker Diagnostic Kits  Market Attractiveness Analysis by Region, 2018–2026
Figure 26: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 27: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 28: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 29: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 30: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 31: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 32: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 33: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 34: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 35: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018–2026
Figure 36: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026
Figure 37: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 38: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 39: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 40: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 41: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 42: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 43: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 44: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 45: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 46: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 48: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 49: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 50: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 51: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 52: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 53: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 54: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 55: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 56: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 57: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 58: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 59: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 60: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 61: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 62: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 63: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 64: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 65: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 66: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 67: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 68: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 69: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 70: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 71: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 72: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 73: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 74: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 75: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 76: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 77: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 78: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 79: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018–2026
Figure 80: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 5795
$ 8795

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top